Mortality risks are central to environmental policy benefit assessments, yet the value per statistical life literature has notable gaps regarding population attributes, risk characteristics, and how to synthesize findings across contexts. Nonfatal health impacts receive limited attention despite their substantial contribution to policy benefits, and their valuation relies heavily on proxy measures like averted costs rather than willingness-to-pay estimates.
This special issue seeks recent research addressing these challenges, including improved willingness-to-pay studies for mortality and morbidity effects, better methods for combining and transferring valuation results, and innovative approaches to distributional equity and co-occurring effects in health benefit assessment.